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ABSTRACT
Bothrops punctatus is an endangered, semi-arboreal pitviper species distributed in
Panam´ a, Colombia, and Ecuador, whose venom is poorly characterized. In the
present work, the protein composition of this venom was proﬁled using the ‘snake
venomics’analyticalstrategy.DecomplexationofthecrudevenombyRP-HPLCand
SDS-PAGE, followed by tandem mass spectrometry of tryptic digests, showed that it
consists of proteins assigned to at least nine snake toxin families. Metalloproteinases
are predominant in this secretion (41.5% of the total proteins), followed by C-type
lectin/lectin-likeproteins(16.7%),bradykinin-potentiatingpeptides(10.7%),phos-
pholipases A2 (9.3%), serine proteinases (5.4%), disintegrins (3.8%), L-amino
acid oxidases (3.1%), vascular endothelial growth factors (1.7%), and cysteine-
rich secretory proteins (1.2%). Altogether, 6.6% of the proteins were not identiﬁed.
In vitro, the venom exhibited proteolytic, phospholipase A2, and L-amino acid oxi-
daseactivities,aswellasangiotensin-convertingenzyme(ACE)-inhibitoryactivity,in
agreementwiththeobtainedproteomicproﬁle.CytotoxicactivityonmurineC2C12
myoblasts was negative, suggesting that the majority of venom phospholipases A2
likely belong to the acidic type, which often lack major toxic eVects. The protein
composition of B. punctatus venom shows a good correlation with toxic activities
here and previously reported, and adds further data in support of the wide diversity
of strategies that have evolved in snake venoms to subdue prey, as increasingly being
revealedbyproteomicanalyses.
Subjects Biochemistry, Biodiversity, Toxicology
Keywords Snake venom, Viperidae, Proteomics, Bothrops punctatus
INTRODUCTION
The Chocoan forest lancehead, Bothrops punctatus, known in Colombia as ‘rabo de
chucha’, is a large semi-arboreal pitviper, ranging from 1.0 to 1.5 m in length. Campbell
& Lamar (2004) described its distribution from the Paciﬁc foothills and coastal plain of
eastern Panam´ a through western Colombia to northwestern Ecuador, with an altitudinal
range between 1350 and 2300 m. In Colombia, Daza, Quintana & Otero (2005) reported
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22 January 2014the occurence of B. punctatus in the Cauca and Magdalena river basins of Antioquia to
eastern Choc´ o. Although Bothrops species are clearly predominant in the epidemiology
of snakebite accidents occuring in Colombia (Otero, 1994; Paredes, 2012), published
reports of proven envenomings caused by B. punctatus appear to be rare. The protein
composition of the venom of this species has not been investigated, although at least two
reports characterized its toxicological properties, in comparative studies of snake venoms
fromColombia(Oteroetal.,1992)andEcuador(Kuchetal.,1996),respectively.Thelethal
potency of this venom to mice was highest among the diVerent Bothrops venoms analyzed
in these two studies, being only second to that of Crotalus durissus terriﬁcus venom (Otero
et al., 1992; Kuch et al., 1996). Due to the lack of knowledge on the venom composition
of B. punctata, this work aimed at characterizing its proteomic proﬁle using the ‘snake
venomics’analyticalstrategy(Calvete,Ju´ arez&Sanz,2007;Calvete,2011),incombination
withtheassessmentofitsenzymaticortoxicactivitiesin vitro.
METHODS
Venom
Venom was obtained from two adult Bothrops punctatus specimens collected in the
eastern region of the Department of Antioquia, and kept in captivity at the Serpentarium
of Universidad de Antioquia, Medell´ ın, Colombia, under institutional permission for
Programa de Oﬁdismo/Escorpionismo. Venom samples were centrifuged to remove
debris,pooled,lyophilizedandstoredat 20C.Insomefunctionalassays,pooledvenom
obtained from more than 30 specimens of Bothrops asper, collected in the Departments of
AntioquiaandChoc´ o,wasincludedforcomparativepurposes.
Proteomic proﬁling
For reverse-phase (RP) HPLC separations, 2.5 mg of venom was dissolved in 200 L of
water containing 0.1% triﬂuoroacetic acid (TFA; solution A), centrifuged for 5 min at
15,000g,andloadedonaC18 column(2504.6mm,5mparticle;Teknokroma)using
an Agilent 1200 chromatograph with monitoring at 215 nm. Elution was performed at
1 mL/min by applying a gradient towards solution B (acetonitrile, containing 0.1% TFA),
as follows: 0% B for 5 min, 0–15% B over 10 min, 15–45% B over 60 min, 45–70% B over
10 min, and 70% B over 9 min (Lomonte et al., 2014). Fractions were collected manually,
dried in a vacuum centrifuge, and further separated by SDS-PAGE under reducing or
non-reducing conditions, using 12% gels. Protein bands were excised from Coomassie
blue R-250-stained gels and subjected to reduction with dithiothreitol (10 mM) and
alkylation with iodoacetamide (50 mM), followed by in-gel digestion with sequencing
grade bovine trypsin (in 25 mM ammonium bicarbonate, 10% acetonitrile) overnight on
an automated processor (ProGest Digilab), according to the manufacturer. The resulting
peptide mixtures were analyzed by MALDI-TOF-TOF mass spectrometry on an Applied
Biosystems 4800-Plus instrument. Peptideswere mixed with an equal volume of saturated
-CHCAmatrix(in50%acetonitrile,0.1%TFA),spotted(1L)ontoOpti-TOF384-well
plates, dried, and analyzed in positive reﬂector mode. Spectra were acquired using a
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(ABSciex) spotted on the same plate. Up to 10 precursor peaks from each MS spectrum
were selected for automated collision-induced dissociation MS/MS spectra acquisition
at 2 kV, in positive mode (500 shots/spectrum, laser intensity of 3000). The resulting
spectra were analyzed using ProteinPilot v.4 (ABSciex) against the UniProt/SwissProt
database using the Paragon algorithm at a conﬁdence level of 95%, for the assignment
of proteins to known families. Few peptide sequences with lower conﬁdence scores were
manually searched using BLAST (http://blast.ncbi.nlm.nih.gov). Finally, the relative
abundance of each protein (% of total venom proteins) was estimated by integration of
the peak signals at 215 nm, using Chem Station B.04.01 (Agilent). When a peak from
HPLC contained two or more SDS-PAGE bands, their relative distribution was estimated
bydensitometryusingtheImageLabv.2.0software(Bio-Rad)(Calvete,2011).
Venom activities
Phospholipase A2 activity
Venom phospholipase A2 (PLA2) activity was determined on the monodisperse synthetic
substrate4-nitro-3-octanoyl-benzoicacid(NOBA)(Holzer&Mackessy,1996),intriplicate
wells of microplates. Twenty L of venom solutions, containing 20 g protein, were mixed
with 20 L of water, 200 L of 10 mM Tris, 10 mM CaCl2, 100 mM NaCl, pH 8.0 buVer,
and 20 L of NOBA (0.32 mM ﬁnal concentration). Plates were incubated at 37C, and
the change in absorbance at 425 nm was recorded after 20 min in a microplate reader
(AwarenessTechnology).
Proteolytic activity
Proteolysis was determined upon azocasein (Sigma-Aldrich) as described by Wang, Shih
& Huang (2004). Twenty g of venoms were diluted in 20 L of 25 mM Tris, 0.15 M NaCl,
5 mM CaCl2, pH 7.4 buVer, added to 100 L of azocasein (10 mg/mL) and incubated for
90 min at 37C. The reaction was stopped by adding 200 L of 5% trichloroacetic
acid. After centrifugation, 100 L of supernatants were mixed with an equal volume of
0.5 M NaOH, and absorbances were recorded at 450 nm. Experiments were carried out in
triplicate.
L-amino acid oxidase activity
L-amino acid oxidase (LAAO) activity was determined by adding various concentrations
of venom (2.5–20 g) in 10 L of water to 90 L of a reaction mixture containing 250 mM
l-Leucine, 2 mM o-phenylenediamine, and 0.8 U/mL horseradish peroxidase, in 50 mM
Tris, pH 8.0 buVer, in triplicate wells of a microplate (Kishimoto & Takahashi, 2001). After
incubation at 37C for 60 min, the reaction was stopped with 50 L of 2 M H2SO4, and
absorbanceswererecordedat492nm.
Cytotoxic activity
Cytotoxic activity was assayed on murine skeletal muscle C2C12 myoblasts (ATCC
CRL-1772) as described by Lomonte et al. (1999). Venom (40 g) was diluted in assay
medium (Dulbecco’s Modiﬁed Eagle’s Medium [DMEM] supplemented with 1% fetal
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150 L, after removal of growth medium (DMEM with 10% FCS). Controls for 0 and
100%toxicityconsistedofassaymedium,and0.1%TritonX-100dilutedinassaymedium,
respectively. After 3 h at 37C, a supernatant aliquot was collected to determine the lactic
dehydrogenase (LDH; EC 1.1.1.27) activity released from damaged cells, using a kinetic
assay(WienerLDH-PUV).Experimentswerecarriedoutintriplicate.
ACE inhibitory activity
Theangiotensin-convertingenzyme(ACE)inhibitoryactivityoffraction4fromtheHPLC
separation (see Table 1), which was identiﬁed as a bradykinin-potentiating peptide-like
component, was assayed by the method of Cushman & Cheung (1971) with some
modiﬁcations (Kim et al., 1999). Various concentrations of the fraction, diluted in 20 L,
wereaddedto100Lof10mMN-hippuryl-His-Leusubstratedilutedin2mMpotassium
phosphate, 0.6 M NaCl, pH 8.3 buVer, and 5 mU of ACE (EC 3.4.15.1; 5.1 UI/mg) diluted
in 50% glycerol. The reaction was incubated at 37C for 30 min, and stopped by adding
200 L of 1 NHCl. The produced hippuric acid was extracted by vigorous stirring for
10 s, followed by the addition of 600 L of ethyl acetate, and centrifugation for 10 min at
4000  g. An aliquot of 500 L of organic phase was dried at 95C for 10 min. The residue
wasdissolvedin1mLofwaterand,afterstirring,theabsorbancewasmeasuredat228nm.
The percentage of ACE inhibition (% ACEi) was determined using the following formula;
% ACEi D (Abs Control   Abs sample)/(Abs control   Abs blank). Control absorbance
correspondedtohippuricacidformedaftertheactionofACE,whileblankabsorbancewas
enzymewithoutsubstrate.
Statistical analyses
The signiﬁcance of diVerences between means was assessed by ANOVA, followed by
Dunnett’s test, when several experimental groups were compared with the control group,
or by Student’s t-test, when two groups were compared. DiVerences were considered
signiﬁcantifp < 0:05.
RESULTS AND DISCUSSION
B. punctatus has been included in the ‘red list’, a report categorizing conservation status,
as a threatened species (Carrillo et al., 2005). Very scarce information on its venom is
available in the literature. In comparative studies of snake venoms from Colombia (Otero
et al., 1992) and Ecuador (Kuch et al., 1996), respectively, this venom was found to induce
local eVects such as hemorrhage, edema, and myonecrosis, as well as systemic alterations
such as deﬁbrination, in similarity to venoms from other Bothrops species. Developments
in proteomic techniques have brought new possibilities to examine the detailed toxin
composition of snake venoms, increasing knowledge on their evolution, toxicological
properties, and correlation with clinical features of envenomings (Calvete, Ju´ arez & Sanz,
2007;Calvete,2013;Fox&Serrano,2008;Valenteetal.,2009;Ohler et al., 2010).Therefore,
the venom of B. punctatus was analyzed for the ﬁrst time using proteomic tools, to gain a
deeperunderstandingonitsproteincompositionandrelationshipstotoxicandenzymatic
actions.
Fern´ andez Culma et al. (2014), PeerJ, DOI 10.7717/peerj.246 4/16Table1 AssignmentoftheRP-HPLCisolatedfractionsofBothropspunctatusvenomtoproteinfamiliesbyMALDI-TOF-TOFofselectedpeptide
ionsfromin-geltrypsin-digestedproteinbands.
Peak % Mass (kDa) Peptideion MS/MS-derived
aminoacid
sequence*
Proteinfamily;
relatedprotein
m=z z
1 0.2 - - - unknown
2 0.3 - - - unknown
3 1.6 - - - unknown
4 10.7 - 967.5 1 ZBWAPVBK BPP-like;  Q7T1M3
5 0.8 H10 2259.1
2051.0
2459.0
1
1
1
XARGDDMox DDYCNGXSAGCPR
XRPGABCAEGXCCDBCR
EAGEECDCGTPGNPCCDAATCK
Disintegrin;  Q7SZD9
6 3.0 H10 1902.9
2243.1
2051.0
2459.1
1
1
1
1
GDDMDDYCNGXSAGCPR
XARGDDMDDYCNGXSAGCPR
XRPGABCAEGXCCDBCR
EAGEECDCGTPGNPCCDAATCK
Disintegrin;  Q0NZX5
7 0.3 - - - unknown
8 1.7 H11 2062.0
3134.9
1
1
CGGCCTDESXECTATGBR
ETXVSXXEEHPDEVSHXFRPSCVTAXR
VEGF;  Q90X23
9 1.2 H22 18 2526.1
1537.8
1828.9
1
1
1
SGPPCGDCPSACDNGXCTNPCTK
MEWYPEAAANAER
YFYVCBYCPAGNMR
CRISP;  Q7ZT99
10a 0.4 H38 1561.9 1 SVPNDDEEXRYPK Serine proteinase;
 Q5W960
10b 0.2 H29 28 1206.8
1683.2
2534.5
1069.8
1512.8
3387.8
1
1
1
1
1
1
XMGWGTXSPTK
TYTBWDBDXMXXR
VSYPDVPHCANXNXXDYEVCR
FXVAXYTSR
VXGGDECNXNEHR
DSCBGDSGGPXXCNGBFBGXXSWGVHPCGBR
Serine proteinase;
 Q072L6
10c 0.3 H12 22 - - - unknown
11 1.5 H28 20 1288.7
1190.7
2305.4
1140.6
2477.5
2477.4
1
1
1
1
1
1
NFBMBXGVHSK
XMGWGTXSPTK
AAYPWBPVSSTTXCAGXXBGGK
VSDYTEWXK
VSNSEHXAPXSXPSSPPSVGSVCR
VXGGDECNXNEHR
Serine proteinase;
 Q072L6
12a 1.8 H35 1083.7 1 FXAFXYPGR Serine proteinase;
 Q6IWF1
12b 0.4 H29 22 1517.9
1499.8
2294.3
1279.7
2889.7
1083.7
1
1
1
1
1
1
NDDAXDBDXMXVR
VVGGDECNXNEHR
TNPDVPHCANXNXXDDAVCR
AAYPEXPAEYR
XDSPVSNSEHXAPXSXPSSPPSVGSVCR
FXAFXYPGR
Serine proteinase;
 Q5W959
13–15 0.8 - - - unknown
(continued on next page)
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Peak % Mass (kDa) Peptideion
m=z z
16 3.1 H16 16 1505.7
934.6
1966.1
2064.1
2027.2
2626.4
1786.0
1
1
1
1
1
1
1
CCFVHDCCYGK
YWFYGAK
YXSYGCYCGWGGXGBPK
DATDRCCFVHDCCYGK
DNBDTYDXBYWFYGAK
XDXYTYSBETGDXVCGGDDPCBK
BXCECDRVAATCFR
Phospholipase A2, D49;
 P86389
17a 0.4 H14 21 1928.9 1 DCPPDWSSYEGHCYR C-type lectin/lectin-like;
 P22030
17b 1.7 H15 16 2027.1 1 DNBDTYDXBYWFYGAK Phospholipase A2, D49;
 C9DPL5
17c 0.4 13 1720.8
1505.7
2064.0
1
1
1
Epa NGDVVCGGDDPCBK
CCFVHDCCYGK
DATDRCCFVHDCCYGK
Phospholipase A2, D49;
 P86389
18 2.8 H13 2064.0 1 DATDRCCFVHDCCYGK Phospholipase A2, D49;
 Q9I968
19 0.3 - - - unknown
20 6.2 H13 19 1928.9 1 DCPSDWSPYEGHCYR C-type lectin/lectin-like;
 Q9PS06
21 0.8 - - - unknown
22a 0.9 120 1537.8
1269.7
1
1
ACSNGBCVDVNRAS
SAECTDRFBR
Metalloproteinase;
 Q8AWI5
22b 3.1 H53 48 3185.9
2605.5
2271.3
1388.8
1352.8
1
1
1
1
1
VVXVGAGMSGXSAAYVXANAGHBVTVXEASER
BFGXBXNEFSBENENAWYFXK
XYFAGEYTABAHGWXDSTXK
BFWEDDGXHGGK
SAGBXYEESXBK
L-amino acid oxidase;
 Q6TGQ9
22c 0.9 H13 1636.0
1928.9
1
1
NXBSSDXYAWXGXR
DCPPDWSSYEGHCYR
C-type lectin/lectin-like;
 P22029
23–25a 1.3 H13 1533.7 1 SYGAYGCNCGVXGR Phospholipase A2, K49;
 Q9PVE3
23–25b 1.1 H28, 20 1279.7
14.997
2294.1
1
1
1
AAYPEXPAEYR
VVGGDECNXNEHR
TNPDVPHCANXNXXDDAVCR
Serine proteinase;
 Q5W959
23–25c 0.9 H13, 19 1635.8 1 NXBSSDXYAWXGXR C-type lectin/lectin-like;
 P22029
26 14.4 H23 42 2040.2
1114.6
2257.3
1828.0
1
1
1
1
YXYXDXXXTGVEXWSNK
XHBMVNXMK
DXXNVBPAAPBTXDSFGEWR
YVEXFXVVDHGMFMK
Metalloproteinase;
 P86976
27 2.0 - - - unknown
28a 18.3 H46 42 1552.7
2953.3
2154.2
1
1
1
VCSNGHCVDVATAY
ASMox SECDPAEHCTGBSSECPADVFHK
XTVBPDVDYTXNSFAEWR
Metalloproteinase;
 Q8QG88
(continued on next page)
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MS/MS-derived
aminoacid
sequence*
Proteinfamily;
relatedproteinTable 1 (continued)
Peak % Mass (kDa) Peptideion
m=z z
28b 2.1 21 3261.7
1457.0
1
1
TDXVSPPVCGNYFVEVGEDCDCGSPATCR
XVXVADYXMox FXK
Metalloproteinase;
 O93517
28c 6.2 H14 1635.9
1193.6
1
1
NXBSSDXYAWXGXR
TTDNBWWSR
C-type lectin-like;
 P22029
29a 3.2 H46 2154.2
1609.9
1775.0
1
1
1
XTVBPDVDYTXNSFAEWR
XYEXVNTXNVXYR
YVEFFXVVDBGMVTK
Metalloproteinase;
 Q8QG88
29b 2.1 H14 992.5
1928.8
1842.9
1
1
1
MNWADAER
DCPPDWSSYEGHCYR
MNWADAERFCSEQAK
C-type lectin/lectin-like;
 M1V359
30 2.6 H38 1327.8 1 YXEXVXVADHR Metalloproteinase;
 Q8AWX7
Notes.
* Cysteine residues determined in MS/MS analyses are carbamidomethylated.
X, Leu/Ile; B, Lys/Gln; ox, oxidized; pa, propionamide.
H, reduced, or , non-reduced SDS-PAGE mass estimations, in kDa. Abbreviations for protein families as in Fig. 2.
RP-HPLC of the crude venom resulted in the separation of 30 fractions (Fig. 1C),
which were further subjected to SDS-PAGE (Fig. 1B), in-gel digestion of the excised
bands, and MALDI-TOF-TOF analysis of the resulting peptides. The amino acid
sequences obtained allowed the unambiguous assignment of 29 out of the 37 components
analyzed, to known protein families of snake venoms (Table 1). Protein family relative
abundances were estimated by integration of the chromatographic areas, combined
with gel densitometric scanning. Results showed that the predominant proteins in this
secretion are metalloproteinases (41.5%; SVMP), followed by C-type lectin/lectin-like
proteins (16.7%; CTL), bradykinin-potentiating peptide-like peptides (10.7%; PEP),
phospholipases A2 of both the D49 (8.0%) and K49 (1.3%) subtypes (for a combined
9.3%; PLA2), serine proteinases (5.4%; SP), disintegrins (3.8%; DIS), L-amino acid
oxidases(3.1%;LAO),vascularendothelialgrowthfactor(1.7%;VEGF),andcysteine-rich
secretory proteins (1.2%; CRISP), as summarized in Fig. 2 and Table 1. An estimated
6.6% of the proteins remained unidentiﬁed, and owing to the scarcity of the venom, their
assignmentcouldnotbefurtherpursued.
A recent phylogenetic analysis of the genus Bothrops (sensu lato) by Fenwick et al.
(2009) grouped B. punctatus within the same clade as Bothrops atrox and Bothrops asper.
Since the proteomic proﬁle of the venoms of the latter two species has been reported
(N´ u˜ nez et al., 2009; Alape-Gir´ on et al., 2008), a comparison of their venom compositions,
together with those of two other pitviper species distributed in Colombia, Bothrops
ayerbei (Mora-Obando et al., 2014) and Bothriechis schlegelii (Lomonte et al., 2008), was
compiled (Table 2). Venoms from these ﬁve species have been analyzed by the same
methodological strategy, therefore allowing reliable comparisons. The composition of
B. punctatus venom resembles that of the other Bothrops species listed in Table 2 only
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MS/MS-derived
aminoacid
sequence*
Proteinfamily;
relatedproteinFigure 1 Separation of Bothrops punctatus (A) venom proteins by RP-HPLC (C) and SDS-PAGE (B). Venom was fractionated on a C18 column
(C) by applying an acetonitrile gradient from 0 to 70% (dashed line), as described in Methods. Each fraction was analyzed by SDS-PAGE (B) under
non-reducing (top gels) or reducing (bottom gels) conditions. Molecular weight markers (M) are indicated in kDa, at the left. Tryptic digests of
the excised protein bands were characterized by MALDI-TOF/TOF, as summarized in Table 1. The photograph of B. punctatus was obtained with
permission from www.tropicalherping.com.
in terms of their high content of metalloproteinases (41.5–53.7%), but overall, its
composition departs from the relative protein abundances observed in any of the other
four pitvipers. The high proportion of CTL proteins in B. punctatus is of note, doubling
the abundance observed in B. atrox, and close to that of B. ayerbei, while in contrast such
proteins are expressed only in trace amounts in B. asper, and have not been detected in
B. schlegelii (Table 2). Further, B. punctatus venom presents a modest amount of VEGF
(1.7%), which has not been found in any of the venoms listed in Table 2. Similar
the venom of the arboreal snake B. schlegelii, but also with the terrestrial species B.
Fern´ andez Culma et al. (2014), PeerJ, DOI 10.7717/peerj.246 8/16
toFigure 2 Composition of Bothrops punctatus venom according to protein families, expressed as per-
centages of the total protein content. SP, serine proteinase; PLA2, phospholipase A2; CRISP, cysteine-
rich secretory protein; DIS, disintegrin; PEP, bradykinin-potentiating peptide-like (BPP-like); LAO, L-
amino acid oxidases; SVMP, metalloproteinase; VEGF, vascular endothelium growth factor; CTL, C-type
lectin/lectin-like; UNK, unknown/unidentiﬁed.
ayerbei, the venom of B. punctatus presents a high content of BPP-like peptides, strikingly
diVering from B. asper and B. atrox venoms in this regard. The possible trophic relevance
of these vasoactive peptides among viperids remains elusive, and no clear correlations
with prey types or habitats have been disclosed thus far. BPPs are oligopeptides of 5–14
aminoacidresidues,richinprolineresiduesandoftenpresentingapyroglutamateresidue,
which display bradykinin-potentiating activity. Their pharmacological eVect is related
to the inhibition of angiotensin I-converting enzyme (ACE) (Ianzer et al., 2007). Peak 4
of the HPLC separation of B. punctatus venom components (Fig. 1C) was identiﬁed as a
BPP (Table 1), and its inhibitory activity on ACE was conﬁrmed, showing a half-maximal
inhibitionofthisenzymeat0.9mg/mL(Fig.3A).InterestinsnakevenomBPPsstemsfrom
their potential in the development of hypotensive drugs, as exempliﬁed by Captopril
R .
Overall, the comparison of B. punctatus venom with those of other pitvipers distributed
in Colombia (Table 2) highlights the remarkable divergence of compositional proﬁles that
havearisenthroughtheevolutionanddiversiﬁcationofsnakes(Casewelletal.,2013).
TheproteincompositionofB. punctatusvenomcorrelateswiththeenzymaticactivities
assayed, as well as with those described in earlier studies (Otero et al., 1992; Kuch et al.,
1996). L-amino acid oxidase (Fig. 3C), proteolytic (Fig. 4A), and PLA2 (Fig. 4B) activities
of this venom were corroborated. Interestingly, its proteolytic activity was higher than
that of B. asper venom (Fig. 4A), and this might be related to the stronger hemorrhagic
potency that was reported for B. punctatus venom in comparison to B. asper venom
(Otero et al., 1992). Hemorrhage induced by viperid venoms is mainly dependent on
the proteolytic action of SVMPs upon the microvasculature and its extracellular matrix
support (Bjarnason & Fox, 1994; Guti´ errez et al., 2005), and this eVect can be enhanced by
venom components aVecting haemostasis, such as procoagulant SPs with thrombin-like
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Proteinfamily Snakespecies
Bothrops punctatusa Bothrops atroxb Bothrops asperc Bothriechis schlegeliid Bothrops ayerbeie
Metalloproteinase 41.5 48.5 44.0 17.7 53.7
Phospholipase A2 9.3 24.0 45.1 43.8 0.7
Serine proteinase 5.4 10.9 10.9 5.8 9.3
BPP-like 10.7 0.3 - 13.4 8.3
CRISP 1.2 2.6 0.1 2.1 1.1
C-type lectin/lectin-like 16.7 7.1 0.5 - 10.1
VEGF 1.7 - - - -
L-amino acid oxidase 3.1 4.7 4.6 8.9 3.3
Disintegrin 3.8 1.7 1.4 - 2.3
Kazal type inhibitor - - - 8.3 -
Phosphodiesterase - - - - 0.7
Nerve growth factor - - - - 0.1
unknown 6.6 - - - 1.7
Numberoffamilies 9 8 7 7
Notes.
* Although B. asper and B. schlegelii are found in Colombia, data correspond to venoms from specimens found in Costa Rica.
a Present work.
b N´ u˜ nez et al. (2009).
c Alape-Gir´ on et al. (2008), specimens of Paciﬁc versant.
d Lomonte et al. (2008).
e Mora-Obando et al. (2014).
Figure3 Bothropspunctatusvenomactivities.(A)Inhibitionofangiotensin-convertingenzyme(ACE)
by peak 4 of B. punctatus venom, identiﬁed as a BPP-like peptide (Table 1). Each point represents the
mean  SD of three replicates. (B) L-amino acid oxidase activity of B. punctatus venom. Each point
represents the mean  SD of three replicates.
Fern´ andez Culma et al. (2014), PeerJ, DOI 10.7717/peerj.246 10/16Figure 4 Proteolytic (A), phospholipase A2 (B), and cytotoxic (C) activities of Bothrops punctatus
venom, compared to the venom of Bothrops asper. Proteolytic activity was determined on azocasein,
using 20 g of each venom. Phospholipase A2 activity was determined on 4-nitro-3-octanoyloxy-benzoic
acid, using 20 g of each venom. Cytotoxic activity was determined on C2C12 murine myoblasts, using
40 g of each venom, as described in Methods. Bars represent mean  SD of three replicates. For each
activity, diVerences between the two venoms were signiﬁcant (p < 0:05).
Fern´ andez Culma et al. (2014), PeerJ, DOI 10.7717/peerj.246 11/16activity, or some CTL components and disintegrins that potently interfere with platelets,
among others (Guti´ errez, Escalante & Rucavado, 2009; Calvete et al., 2005). Considering
that the proportion of SVMPs is lower in B. punctatus than in B. asper venom (Table 2),
the higher hemorrhagic action reportedfor the former (Oteroetal., 1992) suggests that its
abundantCTLcomponents(16.7%)mightincludetoxinsthataVectplatelets,ahypothesis
that deserves future investigation. On the other hand, the PLA2 activity of B. punctatus
venom was lower than that of B. asper (Fig. 4B), in agreement with their corresponding
relative contents of these enzymes (Table 2). However, a major contrast was evidenced in
the cytotoxic activity of these two venoms upon myogenic cells in culture, B. punctatus
being essentially devoid of this eVect, while B. asper causing overt cytolysis and LDH
release under identical conditions (Fig. 4C). Since cytolysis of myogenic cells, an in vitro
correlate for in vivo myotoxicity (Lomonte et al., 1999), has been shown to be mediated
mainly by basic PLA2s in the case of viperid venoms (Guti´ errez & Lomonte, 1995; Lomonte
& Rangel, 2012), this ﬁnding anticipates that the catalytically active (D49) PLA2s present
in B. punctatus venom are likely to belong to the acidic type of these enzymes, which
despite frequently having higher enzymatic activity than their basic counterparts, usually
display very low, or even no toxicity (Fern´ andez et al., 2010; Van der Laat et al., 2013). In
contrast, the venom of B. asper is rich in basic D49 and K49 PLA2s/PLA2 homologues
with strong cytolytic and myotoxic eVects (Angulo & Lomonte, 2005; Angulo & Lomonte,
2009) that would explain the present ﬁndings. Although at least one PLA2 component of
B. punctatus venom was shown to belong to the K49 type of catalytically-inactive, basic
PLA2 homologues (fraction 23–25a; Table 1), its low abundance (1.3%) in the venom
wouldbeinagreementwiththeobservedlackofcytotoxicity(Fig.4C).
In summary, the general compositional proﬁle of B. punctatus venom was obtained
through the analytical strategy known as ‘snake venomics’. The present data add to the
growing body of knowledge on the remarkable diversity of compositional strategies
in snake venom ‘cocktails’, in spite of the reduced number of gene families that encode
their proteins/toxins (Casewell et al., 2013; Calvete, 2013). Due to the key adaptive role of
venoms,thisknowledge,incombinationwithtoxicological,ecological,andnaturalhistory
information,couldleadtoadeeperunderstandingoftheevolutionarytrendsandselective
advantages conferred by particular venom compositions in the divergence of snakes. In
addition,compositionaldatamayoVeramorecomprehensivebasistoforeseethefeatures
ofenvenomingsbythispitviperspecies,largelyunreportedintheliterature.
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